18 Va. Admin. Code § 110-20-690 - [Effective until 2/19/2026] Persons or entities authorized or required to obtain a controlled substances registration
A. A person or
entity that maintains or intends to maintain a supply of Schedules II through
VI controlled substances, other than manufacturer samples, in accordance with
provisions of the Drug Control Act (§
54.1-3400 et seq. of the Code of
Virginia) may apply for a controlled substances registration on forms approved
by the board.
B. Persons or
entities that may be registered by the board shall include hospitals without
in-house pharmacies, nursing homes without in-house pharmacies that use
automated drug dispensing systems, ambulatory surgery centers, outpatient
clinics, alternate delivery sites, crisis stabilization units, persons
authorized by the Department of Behavioral Health and Developmental Services to
train individuals on the administration of naloxone and to dispense naloxone
for opioid overdose reversal, emergency medical services agencies, and regional
EMS councils, provided such persons or entities are otherwise authorized by law
and hold required licenses or appropriate credentials to administer the drugs
for which the registration is being sought.
C. In determining whether to register an
applicant, the board shall consider factors listed in subsections A and D of
§
54.1-3423 of the Code of
Virginia and compliance with applicable requirements of this chapter.
1. The proposed location shall be inspected
by an authorized agent of the board prior to issuance of a controlled
substances registration.
2.
Controlled substances registration applications that indicate a requested
inspection date or requests that are received after the application is filed
shall be honored provided a 14-day notice is allowed prior to the requested
inspection date.
3. Requested
inspection dates that do not allow a 14-day notice to the board may be adjusted
by the board to provide 14 days for the scheduling of the inspection.
4. Any person wishing to change an approved
location of the drug stock, make structural changes to an existing approved
drug storage location, or make changes to a previously approved security system
shall file an application with the board and be inspected.
5. Drugs shall not be stocked within the
proposed drug storage location or moved to a new location until approval is
granted by the board.
D.
The application shall be signed by a person who will act as a responsible party
for the controlled substances. The responsible party may be a prescriber,
nurse, pharmacist, pharmacy technician for alternate delivery sites, a person
authorized by the Department of Behavioral Health and Developmental Services to
train individuals on the administration of naloxone and to dispense naloxone
for opioid overdose reversal, or other person approved by the board who is
authorized to administer the controlled substances.
E. The board may require a person or entity
to obtain a controlled substances registration upon a determination that
Schedules II through VI controlled substances have been obtained and are being
used as common stock by multiple practitioners and that one or more of the
following factors exist:
1. A federal, state,
or local government agency has reported that the person or entity has made
large purchases of controlled substances in comparison with other persons or
entities in the same classification or category.
2. The person or entity has experienced a
diversion, theft, or other unusual loss of controlled substances which requires
reporting pursuant to §
54.1-3404 of the Drug Control
Act.
3. The person or entity has
failed to comply with recordkeeping requirements for controlled
substances.
4. The person or entity
or any other person with access to the common stock has violated any provision
of federal, state, or local law or regulation relating to controlled
substances.
F. The board
may issue a controlled substance registration to an entity at which a patient
is being treated by the use of instrumentation and diagnostic equipment through
which images and medical records may be transmitted electronically for the
purpose of establishing a bona fide practitioner-patient relationship and is
being prescribed Schedules II through VI controlled substances when such
prescribing is in compliance with federal requirements for the practice of
telemedicine and the patient is not in the physical presence of a practitioner
registered with the U.S. Drug Enforcement Administration provided:
1. There is a documented need for such
registration, and issuance of the registration of the entity is consistent with
the public interest;
2. The entity
is under the general supervision of a licensed pharmacist or a practitioner of
medicine, osteopathy, podiatry, dentistry, or veterinary medicine;
and
3. The application is signed by
a person who will act as the responsible party for the entity for the purpose
of compliance with provisions of this subsection. The responsible party shall
be a prescriber, nurse, pharmacist, or other person who is authorized by
provisions of §
54.1-3408 of the Code of
Virginia to administer controlled substances.
G. The board may issue a controlled
substances registration to an EMS agency or regional EMS council to receive
controlled substances in Schedules II through VI from a wholesale distributor,
manufacturer, third-party logistics provider, warehouser, or pharmacy. The EMS
agency or regional EMS council shall identify to the board any designated
location to which the EMS agency or regional EMS council may deliver controlled
substances. The EMS agency or regional EMS council shall also obtain a
registration from DEA in accordance with federal law prior to delivery of
Schedules II through V drugs. The EMS agency or regional EMS council shall
identify on the controlled substances registration application the name and
physical address of the designated locations and attest that each designated
location of the EMS agency or regional EMS council complies with the storage
and security requirements of
18VAC110-20-710. Any changes to
the designated locations shall be submitted to the board in advance of
delivering or ceasing to deliver controlled substances to that location and the
designated locations must be approved sites under federal law.
H. An EMS agency receiving only Schedule VI
drugs from a wholesale distributor, manufacturer, third-party logistics
provider, warehouser, or pharmacy or temporarily storing a secured drug kit
within the EMS building when the vehicle is incapable of maintaining
appropriate drug storage temperature or is out of service shall obtain a
controlled substance registration or operate as a designated location of a
registered EMS agency headquarters.
Notes
Statutory Authority: §§ 54.1-2400 and 54.1-3307 of the Code of Virginia.
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.